Roche receives FDA approval for VENTANA ALK (D5F3) CDx Assay to identify lung cancer patients eligible for targeted treatment with LORBRENA (lorlatinib) About 235,000 people in the US will be diagnosed with lung cancer...

Detection of BK virus in urine may be indicative of early infection in immunocompromised transplant patients Early detection is critical as complications due to infection after transplantation are one of the main causes of...

MEDIA RELEASE First commercial test for fully automated high throughput systems to detect and differentiate SARS-CoV-2, influenza A virus and/or influenza B virus with a single sample As COVID-19 and influenza infections can hardly...

Media Release: Roche receives FDA approval for cobas HPV test for use on the cobas 6800/8800 Systems to identify women at risk for cervical cancer More than 99 percent of cervical cancers are caused by persistent high-risk HPV...

Partnership to leverage Illumina's extensive decentralised installed base with Roche's expertise in assay development and to provide broad access to clinical oncology next-generation sequencing Comprehensive genomic testing improves...